Sfoglia per Autore
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
1997 C. Balotta, P. Bagnarelli, M. Violin, A.L. Ridolfo, D. Zhou, A. Berlusconi, S. Corvasce, M. Corbellino, M. Clementi, M. Clerici, M. Moroni, M. Galli
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis
1999 C. Balotta, P. Bagnarelli, S. Corvasce, R. Mazzucchelli, M. C. Colombo, L. Papagno, S. Santambrogio, A. L. Ridolfo, M. Violin, A. Berlusconi, R. Velleca, G. Facchi, M. Moroni, M. Clementi, M. Galli
Prevalence of HIV-1 resistant strains in recent seroconverters
2000 C. Balotta, A. Berlusconi, A. Pan, M. Violin, C. Riva, A. Gori, S. Corvasce, R. Mazzucchelli, G. Facchi, R. Velleca, D. Senese, L. Deho, M. Galli, S. Rusconi, M. Moroni
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region : outcome after treatment in recently infected individuals
2000 C. Balotta, A. Berlusconi, A. Pan, M. Violin, C. Riva, M.C. Colombo, A. Gori, L. Papagno, S. Corvasce, R. Mazzucchelli, G. Facchi, R. Velleca, G. Saporetti, M. Galli, S. Rusconi, M. Moroni
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals
2001 R. Mazzucchelli, S. Corvasce, M. Violin, V. Riva, R. Bianchi, L. Deho, R. Velleca, J. Cibella, M. Bada, M. Moroni, M. Galli, C. Balotta
Processivity and drug-dependence of HIV-1 protease : determinants of viral fitness in variants resistant to protease inhibitors
2003 S. Menzo, A. Monachetti, C. Balotta, S. Corvasce, S. Rusconi, S. Paolucci, F. Baldanti, P. Bagnarelli, M. Clementi
Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters
2004 C. Balotta, S. Corvasce, L. Romano, M. Violin, F. Razzolini, I. Vicenti, A. Marconi, C. Macchiesi, S. Machetti, A. Galli, P. Duca, M. Zazzi
Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters
2006 S. Corvasce, M. Violin, L. Romano, F. Razzolini, I. Vicenti, A. Galli, P. Duca, I. Caramma, C. Balotta, M. Zazzi
Safety of statin therapy in HIV/hepatitis C virus-coinfected patients
2007 L. Milazzo, B. Menzaghi, S. Corvasce, P. Bonfanti, S. Rusconi, A.L. Ridolfo, S. Antinori
Risk factors for HIV/AIDS in a low HIV prevalence site of sub-Saharan Africa
2007 F. Croce, P. Fedeli, M. Dahoma, L. Dehò, M. Ramsan, F. Adorni, S. Corvasce, M. Galli
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms
2008 A. Galli, A. Lai, S. Corvasce, F. Saladini, C. Riva, L. Dehò, I. Caramma, M. Franzetti, L. Romano, M. Galli, M. Zazzi, C. Balotta
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy
2010 C. Riva, A. Lai, I. Caramma, S. Corvasce, M. Violin, L. Dehò, F. Prati, C. Rossi, M.C. Colombo, A. Capetti, M. Franzetti, V. Rossini, G. Tambussi, M. Ciccozzi, B. Suligoi, C. Mussini, G. Rezza, C. Balotta
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile